We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Core Scientific, Inc. (CORZ) Moves 33.0% Higher: Will This Strength Last?
Read MoreHide Full Article
Core Scientific, Inc. (CORZ - Free Report) shares soared 33% in the last trading session to close at $16.36. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 14.1% gain over the past four weeks.
The recent surge in Core Scientific shares can be attributed to renewed buyout talks with CoreWeave, an AI cloud infrastructure provider. According to reports, CoreWeave has re-entered advanced negotiations to acquire Core Scientific, reigniting investor excitement just months after its initial offer was rejected. This time, with Core Scientific’s market cap now exceeding $3.7 billion, the expected deal could come at a much higher premium. Investors are optimistic that a potential acquisition would unlock significant value, especially given Core Scientific’s pivotal role in AI infrastructure and high-performance computing.
This company is expected to post quarterly loss of $0.07 per share in its upcoming report, which represents a year-over-year change of -75%. Revenues are expected to be $83.33 million, down 41% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Core Scientific, Inc., the consensus EPS estimate for the quarter has been revised 2.6% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on CORZ going forward to see if this recent jump can turn into more strength down the road.
Core Scientific, Inc. belongs to the Zacks Financial - Miscellaneous Services industry. Another stock from the same industry, PJT Partners (PJT - Free Report) , closed the last trading session 2.5% higher at $166.36. Over the past month, PJT has returned 7.5%.
For PJT Partners, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.11. This represents a change of -6.7% from what the company reported a year ago. PJT Partners currently has a Zacks Rank of #2 (Buy).
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Core Scientific, Inc. (CORZ) Moves 33.0% Higher: Will This Strength Last?
Core Scientific, Inc. (CORZ - Free Report) shares soared 33% in the last trading session to close at $16.36. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 14.1% gain over the past four weeks.
The recent surge in Core Scientific shares can be attributed to renewed buyout talks with CoreWeave, an AI cloud infrastructure provider. According to reports, CoreWeave has re-entered advanced negotiations to acquire Core Scientific, reigniting investor excitement just months after its initial offer was rejected. This time, with Core Scientific’s market cap now exceeding $3.7 billion, the expected deal could come at a much higher premium. Investors are optimistic that a potential acquisition would unlock significant value, especially given Core Scientific’s pivotal role in AI infrastructure and high-performance computing.
This company is expected to post quarterly loss of $0.07 per share in its upcoming report, which represents a year-over-year change of -75%. Revenues are expected to be $83.33 million, down 41% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Core Scientific, Inc., the consensus EPS estimate for the quarter has been revised 2.6% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on CORZ going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Core Scientific, Inc. belongs to the Zacks Financial - Miscellaneous Services industry. Another stock from the same industry, PJT Partners (PJT - Free Report) , closed the last trading session 2.5% higher at $166.36. Over the past month, PJT has returned 7.5%.
For PJT Partners, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.11. This represents a change of -6.7% from what the company reported a year ago. PJT Partners currently has a Zacks Rank of #2 (Buy).